🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of Tylenol, alleging the corporations withheld safety concerns that the medication presented to pediatric cognitive development.

The lawsuit follows a month after Donald Trump promoted an unsubstantiated connection between taking Tylenol - referred to as acetaminophen - while pregnant and autism spectrum disorder in young ones.

The attorney general is filing suit against J&J, which previously sold the medication, the exclusive pain medication approved for expectant mothers, and Kenvue, which presently makes it.

In a official comment, he claimed they "deceived the public by making money from discomfort and promoting medication regardless of the risks."

The manufacturer states there is insufficient reliable data connecting acetaminophen to autism spectrum disorder.

"These companies misled for generations, deliberately risking numerous people to boost earnings," Paxton, from the Republican party, said.

The company commented that it was "seriously troubled by the spread of false claims on the reliability of paracetamol and the potential impact that could have on the welfare of American women and children."

On its website, Kenvue also said it had "consistently assessed the relevant science and there is insufficient valid information that shows a proven link between using acetaminophen and autism."

Groups acting on behalf of physicians and healthcare providers share this view.

The leading OB-GYN organization has said acetaminophen - the key substance in Tylenol - is a restricted selection for pregnant women to manage pain and fever, which can pose major wellness concerns if not addressed.

"In more than two decades of studies on the consumption of paracetamol in pregnancy, zero credible investigations has conclusively proven that the usage of paracetamol in any period of gestation results in neurological conditions in offspring," the organization said.

The court filing cites latest statements from the former administration in claiming the drug is potentially dangerous.

Recently, Trump raised alarms from public health officials when he instructed women during pregnancy to "struggle intensely" not to consume Tylenol when ill.

Federal regulators then issued a notice that doctors should contemplate reducing the consumption of acetaminophen, while also mentioning that "a direct connection" between the medication and autism spectrum disorder in children has not been established.

The Health Department head RFK Jr, who manages the FDA, had vowed in spring to conduct "a massive testing and research effort" that would determine the source of autism spectrum disorder in a matter of months.

But specialists warned that identifying a sole reason of autism - considered by experts to be the consequence of a complex mix of genetic and surrounding conditions - would not be simple.

Autism is a type of permanent neurological difference and disability that impacts how persons perceive and engage with the surroundings, and is identified using medical professional evaluations.

In his legal document, the attorney general - a Trump ally who is campaigning for US Senate - asserts the manufacturer and Johnson & Johnson "intentionally overlooked and sought to suppress the science" around paracetamol and autism spectrum disorder.

The lawsuit attempts to require the firms "destroy any commercial messaging" that states Tylenol is safe for expectant mothers.

The Texas lawsuit parallels the concerns of a collection of mothers and fathers of young ones with autism and ADHD who sued the makers of acetaminophen in 2022.

A federal judge threw out the legal action, saying research from the plaintiffs' authorities was inconclusive.